Project PsiloinPsiloBack to the future: Research renewed on the clinical utility of psychedelic drugsFirst set of comments from the December 2016 special Psilocybin issue of the Journal of PsychopharmacologyJul 11, 2017Jul 11, 2017
Project PsiloinPsiloSurvey study of challenging experiences after ingesting psilocybin mushroomsFor this study, 1993 individuals (mean age 30 yrs; 78% male) completed an online survey about their single most psychologically difficult…Jul 11, 2017Jul 11, 2017
Project PsiloinPsiloPsilocybin produces substantial and sustained decreases in depression and anxiety in patientsA randomized double-blind trial: High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and…Jul 11, 2017Jul 11, 2017
Project PsiloinPsiloResearch into psychedelics shut down for decades is now yielding exciting resultsThe Trip Treatment: On an April Monday in 2010, Patrick Mettes, a fifty-four-year-old television news director being treated for a cancer…Feb 16, 2017Feb 16, 2017
Project PsiloinPsiloNew study shows magic mushrooms repair brain damage caused by extreme traumaA new study by The University of South Florida has found that low doses of the active ingredient in magic mushrooms repairs brain damage…Feb 12, 2017Feb 12, 2017
Project PsiloinPsiloTakeaways from Psilocybin for anxiety and depression in cancer careEditorial by David Nutt from the special Psilocybin issue of the Journal of Psychopharmacology vol 30, 2016.Feb 12, 2017Feb 12, 2017
Project PsiloinPsiloRapid and sustained symptom reduction following psilocybin treatment for anxiety and depressionFirst study from the December 2016 special Psilocybin issue of the Journal of Psychopharmacology, by Ross et al (with great thanks to all…Feb 12, 2017Feb 12, 2017
Project PsiloinPsiloPsilocybin Actually Inhibits The Processing Of Negative Emotions In The BrainPsilocybin is known for captivating its imbiber with novel thought and emotional surrender. These mystical experiences can be powerful…Feb 12, 2017Feb 12, 2017